# Big Rock Partners Acquisition Corp. (BRPA)

Source: https://www.quantisnow.com/company/BRPA
Generated: 2026-11-20T00:41:25.540Z

- Ticker: BRPA
- Exchange: NASDAQ
- Sector: Finance
- Industry: Business Services
- IPO year: 2017

## Latest BRPA news and filings

- 2021-08-17 01:32 UTC [Earnings Date] [NRx Pharmaceuticals Announces 2nd Quarter 2021 Financial Update](https://www.quantisnow.com/insight/nrx-pharmaceuticals-announces-2nd-quarter-2021-financial-update-1675458)
- 2021-06-04 14:17 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Big Rock Partners Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-big-rock-partners-acquisition-961751)
- 2021-06-04 13:40 UTC [SEC Form 4] [SEC Form 4: BRAC Lending Group LLC returned 869,565 units of Common Stock to the company, decreasing direct ownership by 60% to 590,435 units (Amendment)](https://www.quantisnow.com/insight/sec-form-4-brac-lending-group-llc-returned-869565-units-961624)
- 2021-06-03 21:30 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-big-rock-partners-acquisition-958275)
- 2021-05-28 21:26 UTC [SEC Form 8-K] [SEC Form 8-K filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-big-rock-partners-acquisition-corp-901761)
- 2021-05-28 21:26 UTC [SEC Form 8-K] [Big Rock Partners Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-filed-sec-form-8-k-entry-901740)
- 2021-05-26 21:02 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Big Rock Partners Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-big-rock-partners-acquisition-863758)
- 2021-05-26 20:13 UTC [SEC Form 8-K] [SEC Form 8-K filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-big-rock-partners-acquisition-corp-862286)
- 2021-05-26 01:17 UTC [SEC Form 4] [SEC Form 4 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-4-filed-by-big-rock-partners-acquisition-corp-847968)
- 2021-05-26 00:02 UTC [SEC Form 4] [SEC Form 4 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-4-filed-by-big-rock-partners-acquisition-corp-847657)
- 2021-05-25 10:48 UTC [NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)](https://www.quantisnow.com/insight/nrx-pharmaceuticals-inc-commences-trading-on-nasdaq-as-nrxp-following-832910)
- 2021-05-24 20:35 UTC [SEC Form 25-NSE filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-big-rock-partners-acquisition-corp-826626)
- 2021-05-24 20:34 UTC [SEC Form 25-NSE filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-big-rock-partners-acquisition-corp-826587)
- 2021-05-24 04:15 UTC [SEC Form EFFECT filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-big-rock-partners-acquisition-corp-815574)
- 2021-05-21 22:40 UTC [Public Offering] [Big Rock Partners Acquisition Corp. Announces Effectiveness of Registration Statement; Confirms Annual Meeting Date of May 24, 2021 to Approve Proposed Merger with NeuroRx](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-announces-effectiveness-of-registration-statement-810344)
- 2021-05-21 19:17 UTC [SEC Form 424B3 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-big-rock-partners-acquisition-corp-805907)
- 2021-05-21 10:42 UTC [SEC Form S-4/A filed by Big Rock Partners Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-big-rock-partners-acquisition-corp-797578)
- 2021-05-20 12:58 UTC [SEC Form S-4/A filed by Big Rock Partners Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-big-rock-partners-acquisition-corp-782301)
- 2021-05-14 21:01 UTC [SEC Form NT 10-Q filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-big-rock-partners-acquisition-745811)
- 2021-05-14 15:02 UTC [SEC Form 425] [SEC Form 425 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-big-rock-partners-acquisition-corp-743669)
- 2021-05-11 20:17 UTC [SEC Form 8-K] [Big Rock Partners Acquisition Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-filed-sec-form-8-k-non-reliance-731668)
- 2021-04-28 18:12 UTC [NeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia](https://www.quantisnow.com/insight/neurorx-and-georgian-ministry-of-health-agree-to-initiate-expanded-666367)
- 2021-04-26 13:35 UTC [Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press Briefing by White House COVID-19 Response Team](https://www.quantisnow.com/insight/dr-anthony-fauci-confirms-zyesami-phase-3-trial-with-remdesivir-652493)
- 2021-04-21 21:15 UTC [SEC Form 8-K] [Big Rock Partners Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-filed-sec-form-8-k-amendments-640486)
- 2021-04-19 21:23 UTC [SEC Form 425] [SEC Form 425 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-big-rock-partners-acquisition-corp-630611)
- 2021-04-19 21:22 UTC [SEC Form 8-K] [Big Rock Partners Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-filed-sec-form-8-k-regulation-630606)
- 2021-04-19 19:57 UTC [NeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI development](https://www.quantisnow.com/insight/neurorx-responds-to-issues-raised-by-relief-therapeutics-regarding-zyesami-629958)
- 2021-04-16 16:55 UTC [SEC Form S-4/A filed by Big Rock Partners Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-big-rock-partners-acquisition-corp-624844)
- 2021-04-07 22:35 UTC [Public Offering] [Big Rock Partners Acquisition Corp. Clarifies Procedure for Stockholder Conversions and Urges Stockholders To Vote "For" Extension Amendment Proposal](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-clarifies-procedure-for-stockholder-conversions-598004)
- 2021-04-06 05:01 UTC [NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir](https://www.quantisnow.com/insight/neurorx-announces-zyesami-aviptadil-has-been-selected-for-inclusion-in-588335)
- 2021-04-01 21:30 UTC [SEC Form 10-K] [SEC Form 10-K filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-big-rock-partners-acquisition-corp-579674)
- 2021-04-01 21:13 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-big-rock-partners-acquisition-579521)
- 2021-04-01 10:01 UTC [SEC Form NT 10-K filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-big-rock-partners-acquisition-575249)
- 2021-03-29 12:31 UTC [SEC Form 425] [SEC Form 425 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-big-rock-partners-acquisition-corp-560285)
- 2021-03-29 12:31 UTC [SEC Form 8-K] [Big Rock Partners Acquisition Corp. filed SEC Form 8-K: Regulation Fd Disclosure, Financial Statements And Exhibits](https://www.quantisnow.com/insight/big-rock-partners-acquisition-corp-filed-sec-form-8-k-regulation-560280)
- 2021-03-29 05:05 UTC [Conference Announcement] [NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19](https://www.quantisnow.com/insight/neurorx-announces-zyesami-aviptadil-rlf-100-met-the-primary-endpoint-of-558917)
- 2021-03-26 13:35 UTC [NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure](https://www.quantisnow.com/insight/neurorx-announces-completion-of-data-analysis-in-phase-2b3-clinical-556503)
- 2021-03-22 10:07 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-big-rock-partners-acquisition-533954)
- 2021-03-22 10:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-big-rock-partners-acquisition-corp-533947)
- 2021-03-22 10:03 UTC [SEC Form 425] [SEC Form 425 filed by Big Rock Partners Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-big-rock-partners-acquisition-corp-533938)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BRPA
- Earnings history: https://www.quantisnow.com/earnings/BRPA
- Dividend history: https://www.quantisnow.com/dividends/BRPA
- Insider transactions: https://www.quantisnow.com/insiders/BRPA
- Options chain: https://www.quantisnow.com/options/BRPA
- SEC 8-K filings only: https://www.quantisnow.com/company/BRPA/8-k
- RSS and alerts for BRPA: https://www.quantisnow.com/docs/rss-feeds.md
